top of page
Search

Understanding Thyroid Function Tests: From Basic Panels to Specialty Diagnostics

ree

(Audio #1) Understanding Thyroid Function Tests
(Audio #2) Understanding Thyroid Function Tests

The thyroid gland plays a central role in regulating metabolism, energy production, and hormonal balance. When thyroid dysfunction is suspected, physicians typically begin with standard laboratory tests. However, in recent years, specialty thyroid function tests—informed by scientific research—have provided deeper insights into complex cases.


1. Standard Thyroid Function Tests

The most common initial tests include:

  • TSH (Thyroid-Stimulating Hormone): Measures pituitary response; elevated in hypothyroidism and suppressed in hyperthyroidism.

  • Free T4 (Thyroxine) and Free T3 (Triiodothyronine): Indicate actual thyroid hormone levels available to cells.

  • Total T4 and T3: Less accurate due to binding proteins but still occasionally used.

These tests are useful for screening and routine monitoring, yet they can miss subtle dysfunctions such as cellular resistance or early autoimmune activity [1].


2. Reverse T3 (rT3)

Reverse T3 is a metabolically inactive form of T3. During stress, illness, or chronic inflammation, the body may convert more T4 into rT3 instead of active T3. Elevated rT3 can indicate thyroid hormone resistance at the cellular level, even if TSH and free T3 appear normal [2].


3. Thyroid Antibodies

Autoimmune thyroid diseases are the most common causes of hypothyroidism (Hashimoto’s) and hyperthyroidism (Graves’). Relevant antibody tests include:

  • Thyroid Peroxidase Antibodies (TPO Ab): Elevated in Hashimoto’s thyroiditis.

  • Thyroglobulin Antibodies (TgAb): are autoantibodies directed against thyroglobulin, a key glycoprotein involved in the synthesis and storage of thyroid hormones. The presence of TgAb is a hallmark of autoimmune thyroid diseases, particularly Hashimoto’s thyroiditis and, to a lesser extent, Graves’ disease. Testing for TgAb is clinically valuable in supporting the diagnosis of autoimmune thyroiditis, especially when thyroid peroxidase antibodies (TPO Ab) are negative, and it's useful in thyroid cancer monitoring [11-13].

  • TSH Receptor Antibodies (TRAb): are autoantibodies that target the thyroid-stimulating hormone (TSH) receptor, either stimulating or blocking its function. The stimulating type (Thyroid-stimulating immunoglobulin -TSI or TSAb) is a defining feature of Graves’ disease, leading to unregulated thyroid hormone production and hyperthyroidism. Testing for TRAb is highly beneficial for confirming the diagnosis of Graves’ disease, especially in ambiguous cases, such as subclinical hyperthyroidism or during pregnancy when radioactive iodine testing is contraindicated. TRAb levels can also predict the risk of Graves’ orbitopathy and help monitor response to antithyroid therapies, as declining TRAb levels often correlate with remission [6,8-10].

These tests help confirm autoimmune origins even before symptoms or TSH levels are significantly altered.


4. T3 Uptake and Free Thyroxine Index (FTI)

Though largely replaced by direct Free T4 and Free T3 assays, these older tests are sometimes used to assess binding protein levels, especially when non-thyroidal illness affects test interpretation [4].


5. Thyroglobulin (Tg)

Thyroglobulin is a protein produced by thyroid cells and is primarily used as a tumor marker after thyroid cancer treatment. It is measured to detect cancer recurrence [5].


6. Advanced Specialty Testing

Some integrative and research-based clinics now evaluate:

  • Tissue-Level Thyroid Hormone Activity: Using markers like SHBG, cholesterol, and basal temperature [7].

  • Comprehensive Thyroid Panels: Including TSH, free T3, free T4, reverse T3, and antibodies, all in one assay.

  • Adrenal Function Test: Adrenal gland function is intricately connected to thyroid health. Testing adrenal function, particularly cortisol levels, offers multiple benefits when evaluating and managing thyroid disorders.

  • Nutrient Testing: Specific vitamins and minerals are essential for thyroid hormone synthesis, conversion, and cellular utilization. Identifying deficiencies or imbalances through testing can guide personalized interventions and improve thyroid function and symptom resolution.

While not universally adopted, these approaches are gaining support for personalized medicine, especially in patients with persistent symptoms despite “normal labs.”


7. Specialized Imaging

Some cases require tests beyond bloodwork:

  • Thyroid ultrasound is the most commonly used imaging modality, which is the preferred first-line test for assessing thyroid nodules, goiter, and suspected thyroid malignancy [15]. Ultrasound can differentiate solid from cystic nodules, detect microcalcifications, irregular margins, and vascular patterns that may suggest malignancy [16]. It also guides fine-needle aspiration biopsy (FNAB) with precision.

  • Radioactive Iodine Uptake (RAIU) test evaluates the thyroid's ability to absorb iodine. This test is especially valuable in differentiating causes of thyrotoxicosis (elevated thyroid hormones causing symptoms), such as distinguishing Graves’ disease (characterized by elevated iodine uptake) from thyroiditis (typically showing low uptake) [8]. RAIU also assists in identifying toxic multinodular goiter and toxic adenoma, where uptake is localized to overactive nodules [14]. Furthermore, RAIU plays a role in pre-treatment planning and post-treatment monitoring in patients undergoing radioactive iodine therapy for hyperthyroidism or thyroid cancer [15].

  • CT, MRI, or PET-CT - In cases of suspected thyroid cancer metastasis or recurrence, these imaging may be useful in certain population [17].


Conclusion

While standard thyroid tests remain the cornerstone of diagnosis, specialty tests informed by evolving research offer clinicians more nuanced insights. Understanding both conventional and advanced assessments allows for more precise diagnosis, monitoring, and personalized care.


Disclaimer: The information provided in this article is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making changes to your diet, lifestyle, or health care regimen.


References:

  1. Garber JR, Cobin RH, Gharib H, et al. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the ATA and AACE. Endocr Pract. 2012;18(6):988-1028. doi:10.4158/EP12280.GL

  2. Peeters RP. Reflections on the Function and Measurement of Reverse T3. Nat Rev Endocrinol. 2017;13(10):570-572. doi:10.1038/nrendo.2017.85

  3. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune Thyroid Disorders. Autoimmun Rev. 2015;14(2):174-180. doi:10.1016/j.autrev.2014.10.016

  4. Spencer CA. Clinical Utility of Thyroid Function Tests. Clin Lab Med. 2004;24(1):19-38. doi:10.1016/S0272-2712(03)00070-4

  5. Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid Cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(Suppl 7):vii110-vii119. doi:10.1093/annonc/mds230

  6. Bahn RS. Graves' Ophthalmopathy. N Engl J Med. 2010;362(8):726-738. doi:10.1056/NEJMra0905750

  7. Bianco AC, Kim BW. Deiodinases: Implications of the Local Control of Thyroid Hormone Action. J Clin Invest. 2006;116(10):2571-2579. doi:10.1172/JCI29812

  8. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. doi:10.1089/thy.2016.0229

  9. Kahaly GJ, Bartalena L, Hegedüs L. The Role of TSH Receptor Antibodies in Graves’ Orbitopathy. Nat Rev Endocrinol. 2020;16(2):89-106. doi:10.1038/s41574-019-0306-z

  10. Diana T, Ponto KA, Kahaly GJ. Thyrotropin Receptor Antibodies and Graves' Orbitopathy. Clin Exp Immunol. 2017;189(3):304-309. doi:10.1111/cei.12992

  11. McLeod DS, Cooper DS. The Incidence and Prevalence of Thyroid Autoimmunity. Endocrine. 2012;42(2):252-265. doi:10.1007/s12020-012-9703-2

  12. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab. 1998;83(4):1121-1127. doi:10.1210/jcem.83.4.4693

  13. Netzel BC, Grebe SKG, Carranza Leon BG, et al. Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Clinical Implications. J Clin Endocrinol Metab. 2015;100(8):E1074-E1083. doi:10.1210/jc.2015-1702

  14. Baskin HJ. Radioiodine treatment of hyperthyroidism. Endocr Pract. 2006;12(5):481-487. doi:10.4158/EP.12.5.481

  15. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi:10.1089/thy.2015.0020

  16. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2016;22(5):622-639. doi:10.4158/EP161208.GL

  17. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914-924. doi:10.1001/jama.2018.0898



©2025 by Nazanin Safaei, ND, MS

©2023 by Vivid Health Naturopathic.

bottom of page